{"id":"https://openalex.org/W7216337958","doi":"https://doi.org/10.1158/1535-7163.34055557","title":"Figure S6 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance","display_name":"Figure S6 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance","publication_year":2026,"publication_date":"2026-10-02","ids":{"openalex":"https://openalex.org/W7216337958","doi":"https://doi.org/10.1158/1535-7163.34055557"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.34055557","doi":"https://doi.org/10.1158/1535-7163.34055557","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.34055557","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.34055557","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5155609180","display_name":"Chengxi Li","orcid":"https://orcid.org/0009-0001-6304-7442","observed_orcids":["https://orcid.org/0009-0001-6304-7442"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chengxi Li","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-6304-7442","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069439605","display_name":"Yu\u2010Hsuan A. Chang","orcid":"https://orcid.org/0000-0003-2705-655X","observed_orcids":["https://orcid.org/0000-0003-2705-655X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu-Hsuan Chang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2705-655X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5130704883","display_name":"Minori Maki","orcid":"https://orcid.org/0009-0002-7066-2184","observed_orcids":["https://orcid.org/0009-0002-7066-2184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minori Maki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-7066-2184","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088108345","display_name":"Ikuko Omori","orcid":"https://orcid.org/0000-0002-8040-8764","observed_orcids":["https://orcid.org/0000-0002-8040-8764"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ikuko Omori","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8040-8764","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102884391","display_name":"Naru Sato","orcid":"https://orcid.org/0000-0003-0452-3194","observed_orcids":["https://orcid.org/0000-0003-0452-3194"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naru Sato","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0452-3194","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086241483","display_name":"Susumu Goyama","orcid":"https://orcid.org/0000-0002-9339-1826","observed_orcids":["https://orcid.org/0000-0002-9339-1826"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susumu Goyama","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9339-1826","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054497666","display_name":"Toshio Kitamura","orcid":"https://orcid.org/0000-0001-7855-1767","observed_orcids":["https://orcid.org/0000-0001-7855-1767"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshio Kitamura","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7855-1767","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5079737516","display_name":"Yutaka Enomoto","orcid":"https://orcid.org/0000-0002-6346-9362","observed_orcids":["https://orcid.org/0000-0002-6346-9362"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yutaka Enomoto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6346-9362","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9649999737739563},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7639999985694885},{"id":"https://openalex.org/keywords/molm-13-cells","display_name":"MOLM-13 cells","score":0.8939999938011169},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.7059999704360962},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.6840000152587891},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.8705000281333923},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7207000255584717},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.6948999762535095},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.669700026512146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6597999930381775},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.633899986743927},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5853999853134155},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4952999949455261},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4593000113964081},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.43880000710487366},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.35019999742507935},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.3398999869823456},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.33799999952316284},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3296999931335449},{"id":"https://openalex.org/C204258353","wikidata":"https://www.wikidata.org/wiki/Q7670282","display_name":"THP1 cell line","level":3,"score":0.32100000977516174},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3156999945640564},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.302700012922287},{"id":"https://openalex.org/C21200559","wikidata":"https://www.wikidata.org/wiki/Q7451068","display_name":"Sensitivity (control systems)","level":2,"score":0.28859999775886536},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.28209999203681946},{"id":"https://openalex.org/C2994430510","wikidata":"https://www.wikidata.org/wiki/Q3270846","display_name":"Myeloid cells","level":3,"score":0.25450000166893005}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.34055557","doi":"https://doi.org/10.1158/1535-7163.34055557","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.34055557","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.34055557","doi":"https://doi.org/10.1158/1535-7163.34055557","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.34055557","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7216037521","https://openalex.org/W7215958679","https://openalex.org/W7216300781","https://openalex.org/W7215717337","https://openalex.org/W7216473014","https://openalex.org/W7216099795","https://openalex.org/W7216296666","https://openalex.org/W7215837102","https://openalex.org/W4205353687","https://openalex.org/W7140672247"],"abstract_inverted_index":{"Changes":[0],"in":[1],"body":[2],"weight":[3],"of":[4,14],"mice":[5],"inoculated":[6],"with":[7],"MOLM-13":[8],"VEN-R":[9],"cells":[10],"during":[11],"the":[12],"course":[13],"drug":[15],"treatment.":[16]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-03T00:00:00"}